| First Author | Moechars D | Year | 1999 |
| Journal | J Biol Chem | Volume | 274 |
| Issue | 10 | Pages | 6483-92 |
| PubMed ID | 10037741 | Mgi Jnum | J:53800 |
| Mgi Id | MGI:1333425 | Doi | 10.1074/jbc.274.10.6483 |
| Citation | Moechars D, et al. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274(10):6483-92 |
| abstractText | Transgenic mice overexpressing different forms of amyloid precursor protein (APP), i.e. Wild type or clinical mutants, displayed an essentially comparable early phenotype in terms of behavior, differential glutamatergic responses, deficits in maintenance of long term potentiation, and premature death. The cognitive impairment, demonstrated in F1 hybrids of the different APP transgenic lines, was significantly different from nontransgenic littermates as early as 3 months of age. Biochemical analysis of secreted and membrane-bound APP, C- terminal ''stubs,'' and A beta(40) and A beta(42) peptides in brain indicated that no single intermediate can be responsible for the complex of phenotypic dysfunctions. As expected, the A beta(42) levels were most prominent in APP/London transgenic mice and correlated directly with the formation of amyloid plaques in older mice of this line, Plaques were associated with immunoreactivity for hyperphosphorylated tau, eventually signaling some form of tau pathology. In conclusion, the different APP transgenic mouse lines studied display cognitive deficits and phenotypic traits early in life that dissociated in time from the formation of amyloid plaques and will be good models for both early and late neuropathological and clinical aspects of Alzheimer's disease. |
